Editas Medicine Announces Second Quarter 2016 Results and Update
Exclusive license to high-fidelity Cas9 and Cas9 PAM variants from Massachusetts General Hospital further advances leading genome editing platform Strategic partnership with Adverum to explore delivery of genomic medicines to treat range of genetic eye …